2023 TCFD Report
TCFD Report

2023 TCFD Report

Samsung Biologics has issued 2023 TCFD Report aligned to the recommendations of the Task Force on Climate-Related Financial Disclosures (TCFD). As a leading sustainable CDMO partner, we understand the seriousness of climate change and its impact on public health; therefore, we are stepping up to the challenge of leading our industry towards a sustainable future. Through the TCFD report, we aim to transparently disclose climate-related financial risks, opportunities and business strategies, and provide more decision-useful information to various stakeholders.

Reporting Period
This report covers the period from January 1, 2022 to December 31, 2022 in accordance with the CDP reporting standards and fiscal year criteria. Some matters of materiality herein cover the period up to the third quarter of 2023. For year-by-year comparison of quantitative data, data of four years from 2019 to 2022 are presented in parallel.
Reporting Standards
This report is written in accordance with the TCFD recommendation.
Reporting Scope
Emissions across the entire scope of Samsung Biologics’ business including upstream and downstream processes are estimated in accordance with the CDP standards. According to the 2022 consolidation criteria, Samsung Bioepis, a subsidiary, is included in Scope 1 & 2. Both financial and non-financial information, including entire climate-related performance, has all been prepared in accordance with fiscal years pursuant to our disclosure system. Data related to energy use and GHG emissions have been prepared in accordance with a third party verification.



Your download is ready

Click Download.


Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy


Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.